GIM
Greylin Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-112,515
| Closed | -$1.76M | – | 77 |
|
|
2019
Q1 | $1.76M | Sell |
112,515
-99,940
| -47% | -$1.57M | 0.4% | 36 |
|
|
2018
Q4 | $3.28M | Sell |
212,455
-24,440
| -10% | -$377K | 0.79% | 22 |
|
|
2018
Q3 | $5.1M | Sell |
236,895
-5,110
| -2% | -$110K | 1.1% | 20 |
|
|
2018
Q2 | $5.89M | Sell |
242,005
-5,150
| -2% | -$125K | 1.27% | 19 |
|
|
2018
Q1 | $4.22M | Sell |
247,155
-3,390
| -1% | -$57.9K | 0.92% | 21 |
|
|
2017
Q4 | $4.75M | Buy |
250,545
+20,680
| +9% | +$392K | 1.03% | 19 |
|
|
2017
Q3 | $4.05M | Sell |
229,865
-64,630
| -22% | -$1.14M | 0.93% | 20 |
|
|
2017
Q2 | $9.78M | Buy |
294,495
+79,300
| +37% | +$2.63M | 2.26% | 11 |
|
|
2017
Q1 | $6.91M | Buy |
215,195
+122,340
| +132% | +$3.93M | 1.6% | 12 |
|
|
2016
Q4 | $3.37M | Buy |
+92,855
| New | +$3.37M | 0.81% | 18 |
|
|
2016
Q1 | – | Sell |
-4,365
| Closed | -$287K | – | 77 |
|
|
2015
Q4 | $287K | Sell |
4,365
-500
| -10% | -$32.9K | 0.08% | 57 |
|
|
2015
Q3 | $275K | Sell |
4,865
-1,999
| -29% | -$113K | 0.08% | 45 |
|
|
2015
Q2 | $406K | Sell |
6,864
-1,200
| -15% | -$71K | 0.1% | 43 |
|
|
2015
Q1 | $464K | Sell |
8,064
-2,200
| -21% | -$127K | 0.11% | 43 |
|
|
2014
Q4 | $590K | Sell |
10,264
-450
| -4% | -$25.9K | 0.14% | 40 |
|
|
2014
Q3 | $576K | Sell |
10,714
-1,400
| -12% | -$75.3K | 0.14% | 43 |
|
|
2014
Q2 | $635K | Sell |
12,114
-1,400
| -10% | -$73.4K | 0.15% | 41 |
|
|
2014
Q1 | $714K | Buy |
13,514
+2,215
| +20% | +$117K | 0.17% | 42 |
|
|
2013
Q4 | $453K | Buy |
+11,299
| New | +$453K | 0.11% | 54 |
|